World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02261753
Date of registration: 26/09/2014
Prospective Registration: Yes
Primary sponsor: University College, London
Public title: Evaluating Dietary Intervention Before surgicaL Treatment for Epilepsy EDIBLE
Scientific title: A Randomised Controlled Trial to Compare Seizure Remission Outcome Following Resective Surgery With or Without Prior Treatment With Ketogenic Diet in Children With Epilepsy the Result of Focal Cortical Dysplasia Type II
Date of first enrolment: October 2014
Target sample size: 3
Recruitment status: Terminated
URL:  https://clinicaltrials.gov/show/NCT02261753
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Austria Belgium Czech Republic Czechia France Germany Italy Switzerland
United Kingdom United States
Contacts
Name:     J Helen Cross, MB ChB PhD
Address: 
Telephone:
Email:
Affiliation:  UCL-London
Key inclusion & exclusion criteria

Inclusion Criteria:

1. Children aged 3 - 15 years;

2. MRI changes consistent with a diagnosis of FCD type II a or b;

3. History of at least two epileptic seizures in the past 6 months before randomisation;

4. Seizure semiology consistent with focal onset, agreed after pre-surgical discussion to
be surgically treatable;

5. Parent/ legal representative willing to give consent.

Exclusion Criteria:

1. Previous use of the KD;

2. Not a surgical candidate for FCD resection;

3. Administration of the KD is medically contraindicated.



Age minimum: 3 Years
Age maximum: 15 Years
Gender: All
Health Condition(s) or Problem(s) studied
Cortical Dysplasia
Intervention(s)
Dietary Supplement: Classical ketogenic diet
Primary Outcome(s)
Time to 6 month remission [Time Frame: Month 33]
Secondary Outcome(s)
Time to first seizure from date of randomisation; [Time Frame: 33 months]
Time to 12 month remission after randomisation [Time Frame: 45 months]
Methylation changes in tissue (DNA) from children pre-treated with the ketogenic diet compared to those not pretreated [Time Frame: 60 months]
Proportion of immediate AEs following resective surgery (i.e. surgical complications within 30 days) [Time Frame: 45 months]
Compare the general AE occurrence [Time Frame: 60 months]
Quality of life at 12 (and at 24 months if enough time for follow-up is available) [Time Frame: 45 months]
Adaptive behaviour assessment at 12 months, after randomisation (and at 24 months if enough time for follow-up is available); [Time Frame: 45 months]
Time to 24 month remission after randomisation (if enough time for follow-up is available) [Time Frame: 45 months]
Changes in peripheral DNA (blood platelets) following treatment with the KD [Time Frame: 60 months]
Secondary ID(s)
13/0688
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
University of Liverpool
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history